Arvinas (ARVN) Cash from Investing Activities (2017 - 2026)

Arvinas (ARVN) recorded quarterly Cash from Investing Activities of $13.7 million in Q1 2026, down 90.6% quarter-over-quarter from $145.8 million in Q4 2025, and down 80.29% on a YoY basis from $69.5 million in Q1 2025.

Arvinas (ARVN) Cash from Investing Activities (2017 - 2026) Analysis & Trends

Arvinas' Cash from Investing Activities history runs 10 years deep, the most recent figure standing at $13.7 million for Q1 2026.

  • In Q1 2026, Cash from Investing Activities fell 80.29% year-over-year to $13.7 million; the TTM figure through Mar 2026 stood at $351.8 million (up 51.64% YoY), while the FY2025 annual figure was $407.6 million, up 1074.64% from the prior year.
  • Cash from Investing Activities was $13.7 million for Q1 2026 at Arvinas, down from $145.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $145.8 million in Q4 2025 to a low of -$127.8 million in Q1 2024.
  • Historically, Cash from Investing Activities has averaged $53.1 million across 5 years, with a median of $63.5 million in 2025.
  • Biggest YoY gain for Cash from Investing Activities was 1511.63% in 2023; the steepest drop was 376.8% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at $19.4 million in 2022, then slumped by 376.8% to -$53.7 million in 2023, then surged by 284.17% to $98.9 million in 2024, then jumped by 47.42% to $145.8 million in 2025, then tumbled by 90.6% to $13.7 million in 2026.
  • The last three Cash from Investing Activities figures came in at $13.7 million (Q1 2026), $145.8 million (Q4 2025), and $63.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.89 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 638.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -431.90 Mn
9 Abivax 91.96 Bn 91.96 Bn - 579,519.10
10 Arvinas 492.16 Mn -122.74 Mn - 13.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 13.70 Mn
Mar 31, 2026 13.70 Mn
Dec 31, 2025 145.80 Mn
Dec 31, 2025 145.80 Mn
Sep 30, 2025 63.50 Mn
Sep 30, 2025 63.50 Mn
Jun 30, 2025 128.80 Mn
Jun 30, 2025 128.80 Mn
Mar 31, 2025 69.50 Mn
Mar 31, 2025 69.50 Mn
Dec 31, 2024 98.90 Mn
Dec 31, 2024 98.90 Mn
Sep 30, 2024 50.50 Mn
Sep 30, 2024 50.50 Mn
Jun 30, 2024 13.10 Mn
Jun 30, 2024 13.10 Mn
Mar 31, 2024 -127.80 Mn
Mar 31, 2024 -127.80 Mn
Dec 31, 2023 -53.70 Mn
Dec 31, 2023 -53.70 Mn